Best clinical practice
08 Aug 2018
The following consensus statement and clinical guideline have been developed with ESPE’s support:
Diagnosis and management of pseudohypoparathyroidism and related disorders: first international consensus statement Mantovani et al. 2018 Nature Reviews Endocrinology 14 476–500
Endocrine treatment of gender-dysphoric/gender-incongruent persons: an Endocrine Society Clinical Practice Guideline Hembree et al. 2017 Journal of Clinical Endocrinology & Metabolism 102 3869–3903
Remember, if you’d like ESPE to develop or endorse a new guideline, a member of our Clinical Practice Committee must be involved throughout the development process. More guidance for consensus meetings and guideline development is available on our website.